GENELUX CORPORATION Increase (Decrease) in Accrued Taxes Payable
GENELUX CORPORATION (GNLX) reported Increase (Decrease) in Accrued Taxes Payable of -$688.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2026-08-13
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for the quarter ending 2026-06-30 was -$108.00K.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for the quarter ending 2026-03-31 was -$580.00K.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for the quarter ending 2025-12-31 was $655.00K, a 105.97% increase year-over-year.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for the quarter ending 2025-09-30 was $170.00K, a 0.59% increase year-over-year.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for fiscal 2025 was $438.00K.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for fiscal 2024 was -$1.11M.
- GENELUX CORPORATION increase (decrease) in accrued taxes payable for fiscal 2023 was -$735.00K.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$688.00K 10-Q · filed 2026-08-13 | -$33.00K derived: sum of 3 quarters · filed 2026-08-13 | $137.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$580.00K 10-Q · filed 2026-05-07 | $75.00K derived: sum of 2 quarters · filed 2026-05-07 | $245.00K derived: sum of 3 quarters · filed 2026-05-07 | $198.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $825.00K derived: sum of 2 quarters · filed 2026-03-19 | $778.00K derived: sum of 3 quarters · filed 2026-08-13 | $438.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $123.00K derived: sum of 2 quarters · filed 2026-08-13 | -$217.00K 10-Q · filed 2025-11-05 | $101.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$387.00K 10-Q · filed 2026-08-13 | -$69.00K derived: sum of 3 quarters · filed 2026-08-13 | $100.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$340.00K 10-Q · filed 2026-05-07 | -$22.00K derived: sum of 2 quarters · filed 2026-05-07 | $147.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.24M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $487.00K derived: sum of 2 quarters · filed 2026-03-19 | -$904.00K derived: sum of 3 quarters · filed 2026-03-19 | -$1.11M 10-K · filed 2026-03-19 |
| 2024-09-30 | $169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.22M derived: sum of 2 quarters · filed 2025-11-05 | -$1.43M 10-Q · filed 2025-11-05 | -$3.42M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.60M 10-Q · filed 2025-08-07 | -$3.58M derived: sum of 3 quarters · filed 2025-08-07 | -$2.17M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$209.00K 10-Q · filed 2025-05-06 | -$2.19M derived: sum of 2 quarters · filed 2025-05-06 | -$776.00K derived: sum of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$567.00K derived: sum of 2 quarters · filed 2025-03-28 | -$735.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.25M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$168.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |